These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma. Seidensticker R; Ricke J; Seidensticker M Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):319-32. PubMed ID: 25966431 [TBL] [Abstract][Full Text] [Related]
23. New concepts in embolotherapy of HCC. Pesapane F; Nezami N; Patella F; Geschwind JF Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645 [TBL] [Abstract][Full Text] [Related]
30. Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma. Zechlinski JJ; Rilling WS Semin Intervent Radiol; 2013 Mar; 30(1):21-7. PubMed ID: 24436514 [TBL] [Abstract][Full Text] [Related]
31. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. Zane KE; Cloyd JM; Mumtaz KS; Wadhwa V; Makary MS World J Clin Oncol; 2021 Sep; 12(9):725-745. PubMed ID: 34631439 [TBL] [Abstract][Full Text] [Related]
32. Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series. Vermeulen S; De Keukeleire K; Dorny N; Colle I; Van Den Bossche B; Nuttens V; Ooms D; De Bondt P; De Winter O Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835485 [TBL] [Abstract][Full Text] [Related]
33. Intraarterial Therapies for the Management of Hepatocellular Carcinoma. Garg T; Shrigiriwar A; Habibollahi P; Cristescu M; Liddell RP; Chapiro J; Inglis P; Camacho JC; Nezami N Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884412 [TBL] [Abstract][Full Text] [Related]
34. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial. Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA Trials; 2012 Aug; 13():144. PubMed ID: 22913492 [TBL] [Abstract][Full Text] [Related]
35. Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection. Jeong S; Zheng B; Wang J; Chi J; Tong Y; Xia L; Xu N; Zhang J; Kong X; Gu J; Xia Q Int J Biol Sci; 2017; 13(10):1234-1241. PubMed ID: 29104490 [No Abstract] [Full Text] [Related]
37. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience. Kallini JR; Gabr A; Ali R; Abouchaleh N; Riaz A; Baker T; Kulik L; Caicedo J; Salem R; Lewandowski RJ Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709 [TBL] [Abstract][Full Text] [Related]
38. Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Maithel SK; Gamblin TC; Kamel I; Corona-Villalobos CP; Thomas M; Pawlik TM Cancer; 2013 Nov; 119(22):3929-42. PubMed ID: 23963845 [TBL] [Abstract][Full Text] [Related]
39. Significant response to transarterial chemoembolization combined with PD-1 inhibitor and apatinib for advanced intrahepatic cholangiocarcinoma: A case report and literature review. Zhang H; Han C; Zheng X; Zhao W; Liu Y; Ye X J Cancer Res Ther; 2023 Aug; 19(4):1055-1060. PubMed ID: 37675736 [TBL] [Abstract][Full Text] [Related]
40. Chemoembolization and radioembolization. Sangro B Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):909-19. PubMed ID: 25260317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]